Differing effects of rapamycin and mTOR kinase inhibitors on protein synthesis (Q37856368)

24 August 2017

1 reference

title

Differing effects of rapamycin and mTOR kinase inhibitors on protein synthesis (English)

1 reference

24 August 2017

1 reference

3

1 reference

24 August 2017

Valentina Iadevaia

2

0 references

Yilin Huo

series ordinal

1

object named as

Yilin Huo

1 reference

24 August 2017

1 April 2011

1 reference

Biochemical Society Transactions

24 August 2017

1 reference

24 August 2017

39

1 reference

24 August 2017

2

1 reference

24 August 2017

446-450

1 reference

TOR signaling in growth and metabolism

24 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

Signalling to translation: how signal transduction pathways control the protein synthetic machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

Synthesis of the translational apparatus is regulated at the translational level

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

Widespread changes in protein synthesis induced by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

All translation elongation factors and the e, f, and h subunits of translation initiation factor 3 are encoded by 5'-terminal oligopyrimidine (TOP) mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

Activation of a metabolic gene regulatory network downstream of mTOR complex 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390446

21 January 2018

Identifiers

DOI

10.1042/BST0390446

1 reference

24 August 2017

1 reference

PubMed ID

21428917